用选择性TNFR2激动剂进行全身治疗会改变中央和外周免疫反应,并在实验性缺血性中风后暂时改善功能结果

Estrid Thougaard1, Pernille Vinther Nielsen2, Amalie Forsberg3

  • 1Neurobiology Research, Department of Molecular Medicine, University of Southern Denmark, J. B. Winsløwsvej 21 st, 5000 Odense C, Denmark; BRIDGE - Brain Research - Inter Disciplinary Guided Excellence, Department of Clinical Research, University of Southern Denmark, J.B. Winsløwsvej 19, 5000 Odense C, Denmark.

Journal of neuroimmunology
|November 21, 2023
PubMed
概括

刺激瘤亡因子受体2 (TNFR2) 与NewSTAR2改变了小鼠在缺血性中风后的免疫反应. 然而,这种方法并没有改善中风后的长期功能恢复.